Krystal Biotech Announces Pipeline Expansion into Oncology and FDA Acceptance of IND…
PITTSBURGH, July 26, 2023 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company focused on the discovery, development and…